Development Of Plx-R18 Cell Therapy As A Countermeasure For Hematopoietic Acute Radiation Syndrome

Name: Development Of Plx-R18 Cell Therapy As A Countermeasure For Hematopoietic Acute Radiation Syndrome
Start: 2023-07-07
End: -0001-11-30
Location: HEALTH AND HUMAN SERVICES, DEPARTMENT OF

HEALTH AND HUMAN SERVICES, DEPARTMENT OF Israel has Released a tender for Development Of Plx-R18 Cell Therapy As A Countermeasure For Hematopoietic Acute Radiation Syndrome in Healthcare and Medicine. The tender was released on Jul 07, 2023.

Country - Israel

Summary - Development Of Plx-R18 Cell Therapy As A Countermeasure For Hematopoietic Acute Radiation Syndrome

Deadline - login to view

MT reference number - 68498700

Product classification - Medical equipments, pharmaceuticals and personal care products

Organization Details:

Address - Israel

Contact details - 565656565

Tender notice no. - 76454545

MT Ref Id - 68498700

Document Type - Tender Notices

Notice Details and Documents:

Description - A contract has been awarded by HEALTH AND HUMAN SERVICES, DEPARTMENT OF for Development Of Plx-R18 Cell Therapy As A Countermeasure For Hematopoietic Acute Radiation Syndrome to PLURI BIOTECH LTD Haifa ISR. Medical Tenders is not only confined to tenders but we also upload crucial information, from future prospects to past market records.

Mt Ref Id - 68498700

Deadline - Nov 30, -0001

View more tenders for

Healthcare and Medicine Tenders Medical equipments, pharmaceut Tenders Israel Tenders

Similar Tenders :

Most Searched